171 related articles for article (PubMed ID: 7514439)
1. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Dimopoulos MA; Weber DM; Kantarjian H; Keating M; Alexanian R
Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine therapy in Waldenström's macroglobulinemia.
Dimopoulos MA; O'Brien S; Kantarjian H; Pierce S; Delasalle K; Barlogie B; Alexanian R; Keating MJ
Am J Med; 1993 Jul; 95(1):49-52. PubMed ID: 8328496
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine therapy in macroglobulinemic lymphoma.
Kantarjian HM; Alexanian R; Koller CA; Kurzrock R; Keating MJ
Blood; 1990 May; 75(10):1928-31. PubMed ID: 1692487
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary non-caseating granuloma in Waldenström macroglobulinemia.
Fukuda R; Kawada H; Ogawa Y; Yanagi H; Kojima S; Urano T; Chie I; Onizuka M; Fukagawa S; Shimada M; Suzuki R; Takagi A; Hotta T
Tokai J Exp Clin Med; 2005 Jul; 30(2):133-6. PubMed ID: 16146205
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin P; Robertson LE; Keating MJ
Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
[No Abstract] [Full Text] [Related]
9. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
10. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
Hałaburda K; Hellmann A
Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
[TBL] [Abstract][Full Text] [Related]
12. Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
Dimopoulos MA; Kantarjian H; Weber D; O'Brien S; Estey E; Delasalle K; Rose E; Cabanillas F; Keating M; Alexanian R
J Clin Oncol; 1994 Dec; 12(12):2694-8. PubMed ID: 7989946
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.
Lewandowski K; Halaburda K; Hellmann A
Leuk Lymphoma; 2002 Feb; 43(2):361-3. PubMed ID: 11999570
[TBL] [Abstract][Full Text] [Related]
14. Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.
Tetreault SA; Saven A
Leuk Lymphoma; 2000 Mar; 37(1-2):125-30. PubMed ID: 10721776
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine in Waldenstrom's macroglobulinemia.
Leblond V; Choquet S
Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid responsive fludarabine pulmonary toxicity.
Stoica GS; Greenberg HE; Rossoff LJ
Am J Clin Oncol; 2002 Aug; 25(4):340-1. PubMed ID: 12151960
[TBL] [Abstract][Full Text] [Related]
17. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.
Leblond V; Ben-Othman T; Deconinck E; Taksin AL; Harousseau JL; Delgado MA; Delmer A; Maloisel F; Mariette X; Morel P; Clauvel JP; Duboisset P; Entezam S; Hermine O; Merlet M; Yakoub-Agha I; Guibon O; Caspard H; Fort N
J Clin Oncol; 1998 Jun; 16(6):2060-4. PubMed ID: 9626204
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors.
Dimopoulos MA; Weber D; Delasalle KB; Keating M; Alexanian R
Ann Oncol; 1995 Jan; 6(1):49-52. PubMed ID: 7710983
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine in Waldenstrom's macroglobulinemia.
Souchet-Compain L; Nguyen S; Choquet S; Leblond V
Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
[TBL] [Abstract][Full Text] [Related]
20. New initiatives with fludarabine monophosphate in hematologic malignancies.
Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
